SEC (US Securities and Exchange Commission) accuses companies of securities fraud
This article was originally published in Clinica
Executive Summary
The US Securities and Exchange Commission (SEC) has charged three medical device and software companies - HyperBaric Systems, Surgica and Intracom - with securities fraud. HyperBaric, which develops technology to preserve the shelf life of blood platelets, has rejected the charges as "totally unwarranted".